African-Americans with genotype-1 with chronic hepatitis C respond poorly to pegylated-interferon and ribavirin combination treatment as compared to Caucasians

被引：1
|
作者：
Khan, AA [1 ]
Mutchnick, MG [1 ]
Ehrinpreis, MN [1 ]
Dhar, R [1 ]
Siddiqui, FA [1 ]
机构：
[1] Wayne State Univ, Sch Med, Detroit, MI 48202 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2005年 / 100卷 / 09期
关键词：
D O I：
10.14309/00000434-200509001-00311
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
311
引用
收藏
页码：S126 / S126
页数：1
相关论文
共 50 条
  • [31] Similar poor results in genotype 4 chronic hepatitis C treatment with interferon and ribavirin compared with genotype 1 treatment
    Mota, AP
    Graus, J
    Blanco, MA
    Pérez-Muñoz, C
    Villlalgordo, C
    Rodero, R
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2003, 95 (03) : 238 - 239
  • [32] Antiviral response of HCV genotype-1 to consensus interferon and ribavirin compared with pegylated interferon and ribavirin. A preliminary report.
    Sjogren, MH
    Sjogren, R
    Lyons, MF
    Ryan, M
    Santoro, J
    Smith, C
    Reddy, KR
    Bonkovsky, H
    Huntley, B
    Ibarra, L
    Faris-Young, S
    HEPATOLOGY, 2004, 40 (04) : 396A - 397A
  • [33] Safety and efficacy of faldaprevir with pegylated interferon alfa-2a and ribavirin in Japanese patients with chronic genotype-1 hepatitis C infection
    Nishiguchi, Shuhei
    Sakai, Yoshiyuki
    Kuboki, Makoto
    Tsunematsu, Satoshi
    Urano, Yasuhisa
    Sakamoto, Wataru
    Tsuda, Yasuhiro
    Steinmann, Gerhard
    Omata, Masao
    LIVER INTERNATIONAL, 2014, 34 (01) : 78 - 88
  • [34] Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C
    Aizawa, Nobuhiro
    Enomoto, Hirayuki
    Takashima, Tomoyuki
    Sakai, Yoshiyuki
    Iwata, Kazunari
    Ikeda, Naoto
    Tanaka, Hironori
    Iwata, Yoshinori
    Saito, Masaki
    Imanishi, Hiroyasu
    Iijima, Hiroko
    Nishiguchi, Shuhei
    JOURNAL OF GASTROENTEROLOGY, 2014, 49 (08) : 1253 - 1263
  • [35] Chronic hepatitis C: Treatment of pegylated interferon/ribavirin nonresponders
    Shiffman M.L.
    Current Gastroenterology Reports, 2006, 8 (1) : 46 - 52
  • [36] Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin
    Carvalho-Filho, Roberto J.
    Dalgard, Olav
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2010, 3 : 1 - 13
  • [37] Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C
    Nobuhiro Aizawa
    Hirayuki Enomoto
    Tomoyuki Takashima
    Yoshiyuki Sakai
    Kazunari Iwata
    Naoto Ikeda
    Hironori Tanaka
    Yoshinori Iwata
    Masaki Saito
    Hiroyasu Imanishi
    Hiroko Iijima
    Shuhei Nishiguchi
    Journal of Gastroenterology, 2014, 49 : 1253 - 1263
  • [38] Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2
    Seo, Kayo
    Kim, Soo Ki
    Kim, Soo Ryang
    Ohtani, Aya
    Kobayashi, Mana
    Kato, Airi
    Morimoto, Eri
    Saijo, Yuka
    Kim, Ke Ih
    Imoto, Susumu
    Kim, Chi Wan
    Yano, Yoshihiko
    Kudo, Masatoshi
    Hayashi, Yoshitake
    DIGESTIVE DISEASES, 2017, 35 (06) : 541 - 547
  • [39] Treatment of Chronic Hepatitis with Sofosbuvir in Combination with Ribavirin with or without Pegylated Interferon
    Sidhu, Sandeep S.
    Malhi, Nirmaljeet
    Singh, Rupinder
    Gover, Rajiv
    Sidhu, Js
    Bansal, Ajesh
    Goyal, Omesh
    Sidhu, Gursewak
    Nanda, Vijay
    Saluja, Harmeet
    Sehgal, Alok
    Simran, Sidhu
    Kishore, Harsh
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S383 - S383
  • [40] Chronic hepatitis C: Treatment of pegylated interferon/ribavirin nonresponders
    Shiffman M.L.
    Current Hepatitis Reports, 2006, 5 (3) : 114 - 120
12345